Feedback PLC (LON:FDBK)

Feedback PLC (LON:FDBK)

Share Price
0.98 p
-0.025 (-2.50 %)
Market Cap
£3.64 m
Proactive Investors - Run By Investors For Investors

Feedback PLC

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through our trading subsidiary, Feedback Medical Limited.

Their products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, such as cancer. Feedback Medical work with customers globally...

Market: LSE:FDBK
52-week High/Low: 2.50p / 0.63p
Sector: Electronic & Electrical Equipment
Market Cap: £3.64 m
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Feedback PLC

Feedback PLC Timeline

The investment in new hires for Cadran, along with January's agreement with Future Processing, to accelerate Feedback Medical's technology development and innovation, has increased the company's cost base, the principal benefit of which will not be realised until the next financial year.
"Our fund-raiser in November 2018 positions us well to build on the operational progress already achieved and to continue to focus on our longer-term goals of maximising the clinical opportunities for TexRAD® and new business opportunities for Cadran," said Dr Alastair Riddell, the executive chairman of Feedback.
"We are pleased to have received support from existing and new investors. This is a strong endorsement of Feedback and our strategy at a time of general market uncertainty," said executive chairman, Dr Alastair Riddell

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use